These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 15327537)
1. The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Morton DL; Cochran AJ Br J Dermatol; 2004 Aug; 151(2):308-19. PubMed ID: 15327537 [No Abstract] [Full Text] [Related]
2. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon. Wilson LL Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046 [TBL] [Abstract][Full Text] [Related]
4. [Study of variations between surgeons regarding inguinal lymph node clearance in melanoma]. Danino MA; Trost O; Malka G; Garrido I; Jebrane A; Dalac S Ann Dermatol Venereol; 2008 Feb; 135(2):142-4. PubMed ID: 18342100 [No Abstract] [Full Text] [Related]
5. Does the tumor status of the regional lymph nodes really matter in melanoma? Essner R; Morton DL Ann Surg Oncol; 2001 Dec; 8(10):749-51. PubMed ID: 11776484 [No Abstract] [Full Text] [Related]
6. A glimpse of future management of melanoma. Cochran AJ Arch Dermatol; 2009 Oct; 145(10):1176-7. PubMed ID: 19841407 [No Abstract] [Full Text] [Related]
7. Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark. Pawlik TM; Ross MI; Shaw HM; Thompson JF; Gershenwald JE Eur J Surg Oncol; 2005 Apr; 31(3):323-4. PubMed ID: 15780572 [No Abstract] [Full Text] [Related]
9. Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma. Scheri RP; Essner R Expert Rev Anticancer Ther; 2006 Jul; 6(7):1105-10. PubMed ID: 16831081 [TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now. Medalie N; Ackerman AB Br J Dermatol; 2004 Aug; 151(2):298-307. PubMed ID: 15327536 [No Abstract] [Full Text] [Related]
11. Complication rates of completion lymphadenectomy following positive sentinel lymph node biopsy versus therapeutic lymphadenectomy in melanoma. Smith JR; Wilson A; Stone C J Plast Reconstr Aesthet Surg; 2016 Jul; 69(7):1011-2. PubMed ID: 27184594 [No Abstract] [Full Text] [Related]
12. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606 [TBL] [Abstract][Full Text] [Related]
13. [Sentinel lymph node biopsy in melanoma: our experience over 8 years in a universitary hospital]. Bañuelos-Andrío L; Rodríguez-Caravaca G; López-Estebaranz JL; Rueda-Orgaz JA; Pinedo-Moraleda F Cir Cir; 2015; 83(5):378-85. PubMed ID: 26141108 [TBL] [Abstract][Full Text] [Related]
18. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study. Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935 [TBL] [Abstract][Full Text] [Related]
19. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Molenkamp BG; Statius Muller MG; Vuylsteke RJ; van der Sijp JR; Meijier S; van Leeuwen PA Eur J Surg Oncol; 2005 Mar; 31(2):211-2. PubMed ID: 15698742 [No Abstract] [Full Text] [Related]